Neosar Interactions
There are 379 drugs known to interact with Neosar (cyclophosphamide), along with 6 disease interactions. Of the total drug interactions, 55 are major, 294 are moderate, and 30 are minor.
- View all 379 medications that may interact with Neosar
- View Neosar disease interactions (6)
Most frequently checked interactions
View interaction reports for Neosar (cyclophosphamide) and the medicines listed below.
- acetaminophen / codeine
- acetaminophen / hydrocodone
- Adriamycin (doxorubicin)
- Adrucil (fluorouracil)
- aspirin
- Cholestyramine Light (cholestyramine)
- Claritin (loratadine)
- Cosmegen (dactinomycin)
- Coumadin (warfarin)
- Decadron (dexamethasone)
- Decadron Phosphate, Injectable (dexamethasone)
- Eliquis (apixaban)
- Ergamisol (levamisole)
- Ethyol (amifostine)
- Etopophos (etoposide)
- Femara (letrozole)
- Fludara (fludarabine)
- fluticasone
- Hycamtin (topotecan)
- Ifex (ifosfamide)
- Leukeran (chlorambucil)
- Mustargen (mechlorethamine)
- Neulasta (pegfilgrastim)
- Norvasc (amlodipine)
- Oncovin (vincristine)
- Paraplatin (carboplatin)
- Sotalol Hydrochloride AF (sotalol)
- Sustol (granisetron)
- Taxotere (docetaxel)
- Thioplex (thiotepa)
Neosar disease interactions
There are 6 disease interactions with Neosar (cyclophosphamide) which include:
- myelosuppression
- urinary tract obstruction
- cardiac disease/cardiotoxicity
- hepatic dysfunction
- pulmonary impairment
- renal dysfunction
More about Neosar (cyclophosphamide)
- Neosar consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.